ArticleCancer medicine2025

Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib.

E Agostani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.